You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy

Cancers - Switzerland
doi 10.3390/cancers12030706
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer

2019English

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Cd30-Chimeric Antigen Receptor (Car) T Cells for Therapy of Hodgkin Lymphoma (Hl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Chimeric Antigen Receptor T-Cells

Cancer Journal
Cancer ResearchOncology
2015English

394. McSP-Chimeric Antigen Receptor (CAR)-Redirected T Cells Target Multiple Solid Tumors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer

American Journal of Hematology
Hematology
2019English

Chimeric Antigen Receptor (CAR)-redirected T Cells: Is There a Place for Them in Infectious Diseases?

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Combining ROR1- Specific Chimeric Antigen Receptor (CAR) NK Cells With IL-15 Superagonist (N-803/Alt-803) to Target Chemotherapy Resistant Neuroblastoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Cytotoxic Function of Chimeric Antigen Receptor (CAR) T Cells Redirected by Anti-Muci Nanobody

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy